4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-056372
Director sold 7,500 shares at $55.00 ($412,500)
- Director acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CAGNONI PABLO J Director | 2019-11-12 | Option exercise | +7,500 | $5.59 | $41,925 | 7,500 | D |
| CAGNONI PABLO J Director | 2019-11-12 | Sale | −7,500 | $55.00 | $412,500 | 0 | D |
| Derivatives | |||||||
| CAGNONI PABLO J Director | 2019-11-12 | Option exercise · Stock Option (Right to Buy) | −7,500 | 71,333 | D | ||
| Open-market sales · 7,500 sh · avg $55.00 · $412,500 | |||||||
Loading xslF345X03/doc4.xml…